Cargando…
Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial
BACKGROUND: Approximately 50% of patients with major depressive disorder (MDD) do not respond optimally to antidepressant treatments. Given this is a large proportion of the patient population, pretreatment tests that predict which patients will respond to which types of treatment could save time, m...
Autores principales: | Grieve, Stuart M, Korgaonkar, Mayuresh S, Etkin, Amit, Harris, Anthony, Koslow, Stephen H, Wisniewski, Stephen, Schatzberg, Alan F, Nemeroff, Charles B, Gordon, Evian, Williams, Leanne M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729660/ https://www.ncbi.nlm.nih.gov/pubmed/23866851 http://dx.doi.org/10.1186/1745-6215-14-224 |
Ejemplares similares
-
Widespread reductions in gray matter volume in depression()
por: Grieve, Stuart M., et al.
Publicado: (2013) -
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol
por: Williams, Leanne M, et al.
Publicado: (2011) -
Profound and reproducible patterns of reduced regional gray matter characterize major depressive disorder
por: Hellewell, Sarah C., et al.
Publicado: (2019) -
Gender-specific structural abnormalities in major depressive disorder revealed by fixel-based analysis
por: Lyon, Matt, et al.
Publicado: (2019) -
Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder
por: Korgaonkar, Mayuresh S., et al.
Publicado: (2014)